Crossmark

Colloidal chitosan-silver nanoparticles-fluoride nanocomposite as an antibacterial mouthwash against salivary Streptococcus mutans in orthodontic patients (a randomized clinical trial)

Crossref DOI link: https://doi.org/10.1007/s00784-024-05802-3

Published Online: 2024-07-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fakhri, Elaheh

SadrHaghighi, AmirHooman

Sarvari, Raana

Torabi, Mitra

Azizi, Yasaman

Eskandarinezhad, Mahsa

Sedighnia, Negar

Keyhanvar, Peyman

Amirsaadat, Soumayeh
License Information

Text and Data Mining valid from 2024-07-19

Version of Record valid from 2024-07-19
More Information

Article History

Received: 5 November 2023

Accepted: 21 June 2024

First Online: 19 July 2024

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the research ethics committee of Tabriz University of Medical Sciences with reference number IR.TBZMED.REC.1400.169.

: The design of this study was approved by the Tabriz University of Medical Sciences Ethics Committee under the Code of Ethics IR.TBZMED.REC.1400.169. Informed written consent was obtained from all individual participants included in the study.

: This clinical trial has been registered in the Iranian Registry of Clinical Trials with the URL of and a registration number of IRCT20210620051635N1.

: None.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below